eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | melanoma, malignant |
| Symptom | C0426768|o sign |
| Sentences | 14 |
| PubMedID- 23812302 | The plasma levels of pmps, emps, and av(+)mps were higher in stage iv than in the other stages of melanoma, but with no significant difference. |
| PubMedID- 26103029 | Men taking pde5 inhibitors had a higher educational level and annual income, factors that were also significantly associated with melanoma risk. |
| PubMedID- 20607832 | There were no significant associations between cases with thin melanoma and controls. |
| PubMedID- 23299197 | Ipilimumab has been the first agent to significantly improve the survival of metastatic melanoma patients and to provide long-term benefit to a sizeable proportion of patients treated within phase ii/iii studies and expanded access programs. |
| PubMedID- 23905577 | However, single peptide-loaded nps failed to significantly delay the growth of subcutaneously inoculated b16 melanoma cells in a prophylactic setting. |
| PubMedID- 21261790 | Extract led to significant restoration of h-2k(b) -restricted and melanoma-reactive t cells in the spleen and draining lymph nodes of melanoma-bearing mice. |
| PubMedID- 23875712 | No significant effect of mc1r genotype on melanoma prevalence or severity was identified. |
| PubMedID- 25594008 | We detected anxa1 in 82 % of melanoma samples tested, with no significant difference in the frequency of expression between primary and metastatic melanomas. |
| PubMedID- 26158900 | Indeed, a 3-4-fold decrease of etv1 protein levels are observed following mir-17 transfection into the various melanoma lines, with no significant change in etv1 mrna expression. |
| PubMedID- 24709886 | Variable levels of erbb2, erbb3, and truncated erbb4 were expressed in both braf wildtype and mutant melanoma cells with no significant differences between wildtype and mutant lines. |
| PubMedID- 26177116 | There was no significant effect of subsequent pregnancy on melanoma mortality after 11 to 20 years of follow-up (pooled hazard ratio, 0.81; 95% confidence interval, 0.60-1.09) and no significant differences in melanoma recurrence. |
| PubMedID- 22951724 | Hoiom et al (2011) recently analyzed 35 high-risk swedish melanoma pedigrees with no significant findings. |
| PubMedID- 24663820 | Conclusions: the appearance of a ct halo sign in melanoma with lung metastases following til therapy may indicate antitumoral effect and a good response to therapy. |
| PubMedID- 22935625 | In vivo, 4egi-1 and #1181 strongly inhibit tumor growth in xenograft models of human breast and melanoma cancers with no sign of macroscopic- or microscopic-toxicity at therapeutic doses. |
Page: 1